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chloramphenicol has been observed. Western studies have
favored azithromicin as potential drug but due to lack of
breakpoint concentrations in different guidelines; its invitro
interpretation has often been difﬁcult. Purpose of present
study is to assess current susceptibility pattern of blood
isolates of salmonella and evaluate and compare pivotal
role of azithromicin as drug of choice for enteric fever in
India and western countries.
Methods: 107 non-repeat blood isolates of Salmonella spp.
from 2005 2008 in Microbiology Department, SGPGIMS,
Lucknow, India, were subjected to susceptibility testing for
chloramphenicol (30mg), nalidixic acid (30mg), ampicillin
(10mg), trimethoprim-sulphamethoxazole (1.25/23.75 mg),
ceftriaxone (30mg), cefepime (30 mg), ciproﬂoxacin (5 mg),
gatiﬂoxacin (5mg), tetracycline (30 mg), amoxicillin-
clavulanic acid (20/10mg) and oﬂoxacin (5mg) (Oxoid,
Basingstoke, UK) as per Clinical and Laboratory Standards
Institute (CLSI) guidelines. Breakpoint Minimum inhibitory
concentration (MIC), MIC90 & MIC50 were determined against
nalidixic acid, ciproﬂoxacin and azithromicin by E-Test®
(AB Biomerieux, Solona Sweden) and interpreted according
to CLSI guidelines & British Society of Antimicrobial
Chemotherapy breakpoints for azithromicin.
Results: See the tables.
Conclusion: Present study had higher MIC90 values for
azithromicin compared from western isolates thereby
directing a guarded use of antibiotic for enteric fever.
Table 1. Number and distribution of the 107 Salmonella isolates
Species (n) Distributiona, n (%) Resistance
NARS NASS ESBL MDR Azithromycin
MIC  16 mg/ml,
n (%)
Chloramphenicol
resistance,
n (%)
Typhi (80) 70/80
(87.5%)
10/80
(12.5%)
Nil 4/80
(5%)
27/80
(33.75%)
5/80b
(6.25%)
Paratyphi A (21) 21/21
(100%)
Nil Nil Nil 8/21
(38.09%)
Nil
Senftenberg (2) 2/2
(100%)
Nil 2/2
(100%)
Nil 1/2
(50%)
Nil
Typhimurium (3) Nil 3/3
(100%)
Nil Nil Nil Nil
Enteritidis (1) 1/1
(100%)
Nil 1/1
(100%)
Nil Nil Nil
Total (107) 94/107
(87.85%)
13/107
(12.14%)
3/107
(2.80%)
4/107
(3.78%)
36/107
(33.64%)
5/107
(4.67%)
a NARS: nalidixic acid resistant Salmonella; NASS: nalidixic acid sensitive Salmonella; ESBL: extended
spectrum beta lactamase; MDR: multi drug resistant.
b Four were NARS.
Table 2. MIC90 and MIC50 values for three antimicrobials tested
Drug MIC90 (mg/ml) MIC50 (mg/ml)
Nalidixic acid >256 >256
Azithromycin 24 12
Ciproﬂoxacin 0.75 0.38
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Objective: To determine the effect of oral zinc sulfate
supplementation given with coamoxiclav as compared with
coamoxiclav alone for treatment of otitis media with
effusion (OME). The efﬁcacy was assessed 3 and 6 weeks
after administration.
Methods: In a double-blind, randomized trial 4 to 14 years
old children with OME who referred to ear, nose and throat
clinic, were randomly assigned into two groups:
1. Zinc group: Zinc sulfate + Coamoxiclav + Pseudo-
ephedrine + Nacl nasal drop
2. Placebo group: Placebo + Coamoxiclav + Pseudo-
ephedrine + Nacl nasal drop.
Children were examined by otoscopy and tympanometry at
entry and after 3 weeks of treatment. For children who
had not been cured completely after 3 weeks, treatment
continued for more 3 weeks (total of 6 weeks).
Results: A total of 52 children were studied consisting zinc
group 29 and placebo group 23 children. At the end of the
ﬁrst course of treatment (3 weeks) 62.1% of children in the
zinc group had clinical improvement compared with 43.5%
of children in placebo group. Tympanometrically, 70.9% of
children in zinc group had improvement compared with
65.5% for placebo group with no statistically signiﬁcant
difference.
There was no statistically difference between two groups at
the end of second Course of treatment (6 weeks), too. But
the response rate of zinc group was better than the placebo
group (43.8% versus 12.5% clinically and 56.3% versus
40% tympanometrically). Zinc administration and cycles of
treatment had not statistically signiﬁcant relationship.
Conclusion: Although in this study oral zinc sulfate
supplementation had not statistically effect on treatment of
OME, the response rate was better in zinc group compared
to placebo group specially for longer administration.
According to the ﬁndings, it seems more studies about oral
zinc supplementation in the treatment of OME is needed.
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Background and Objectives: Group B Streptococcus (GBS) is
a major cause of neonatal and maternal infections. In this
study the serotype distribution and antibiotic resistance
pattern of 56 GBS strains Isolated from pregnant women in
Ardabil (2009) was determined.
Methods: The MIC for clindamycin, vancomycin, penicillin,
ampicillin and erythromycin against isolates were
determined using E-test strips according to CLSI. Serotyping
was performed using capsular antiserum.
Results: According to MIC tests all isolates were susceptible
to ampicillin, vancomycin and penicillin [MIC range;
0.016 0.12mg/mL, 0.75 0.94mg/mL and 0.064 0.016mg/mL
respectively]. 1 (1.7%) isolate showed reduced-susceptibility
pattern to penicillin (MIC; 0.25 mg/mL) and 16 (28.6%)
had the MIC higher than 0.25mg/ml for vancomycin
(0.25mg/ml considered as sensitive). The MIC range for
erythromycin and clindamycin was 0.5 0.016mg/ml and
16 0.016mg/ml respectively. There were 3 (5.3%) isolates
semi-sensitive (0.25 1mg/ml) to erythromycin (2; 0.5 mg/ml
and 1; 0.38mg/ml) and 2 (3.5%) isolates to clindamycin
(1; 0.5mg/ml, 1; 0.38mg/ml). Additionally 2 (3.5%) isolates
were resistant (MIC1mg/ml) to clindamycin (1; 16mg/ml,
1; 2mg/ml). Serotypes V (19.6%), II (12/5%) and IV (12.5%),
were the most frequent followed by serotypes III (10.7%) and
VI (10.7%), Ib (8/9%), Ia (7.1%), VII (5.3%) and VIII (5.3%);
7.1% of strains were Nontypeable.
Conclusion: Most isolates were sensitive to commonly used
antibiotics. The serotype V was the most frequent one in
this study.
